The number of people with susceptibility test result for rifampicin in Germany
Germany: The number of people with susceptibility test result for rifampicin was 83.72 in 2021. ▬ Flat
Latest (2021)
83.72
Change on year
down 2.7%
World rank
89th
of 146 countries
All-time high
87.61
in 2018
All-time low
83.72
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Germany, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Germany stood at 83.72. That is the lowest value across all 5 years on record.
Compared with earlier readings it is down 2.7% on the previous year and down 3.8% over five years.
That places Germany 89th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Germany, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 87.01 | — |
| 2018 | 87.61 | +0.7% |
| 2019 | 86.72 | -1.0% |
| 2020 | 86.08 | -0.7% |
| 2021 | 83.72 | -2.7% |
Germany compared with similar countries
- Germany's 83.72 is below the median for high income countries, which is 92.6, 90% of the median. (56 countries reporting)
- Germany's 83.72 is below the median for Europe & Central Asia, which is 93.52, 90% of the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 87.11 | 86.72 | 87.61 | 3 |
| 2020s | 84.9 | 83.72 | 86.08 | 2 |
Countries ranked near Germany
More health data for Germany
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9955 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,164 deaths per 1,000 people (2090)
- Number of infants who die before age 1 368 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2000)
- Population ages 00-04, female, annual growth rate -2.18 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0216 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.2 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Germany?
- The number of people with susceptibility test result for rifampicin in Germany was 83.72 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Germany?
- The highest recorded value was 87.61 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Germany?
- The lowest recorded value was 83.72 in 2021.
- How does Germany rank for the number of people with susceptibility test result for rifampicin?
- Germany ranks 89th out of 146 countries with data for 2021.
- Where does this Germany data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).